CUTTING EDGE FOR NASAL SPRAYS - REVOLUTIONIZING DRUG DELIVERY OF NEW DRUGS APPROVED BY FDA

V. Sravan Kumar*, P. Srinivas Babu, B. Sk. Asif Ali, T. Aiswarya, M. Sarah, M. Pallavi, D. Sandhya

The advent of novel nasal spray formulations represents a transformative approach in drug delivery, particularly for new drugs approved by the FDA. This paper explores the cutting-edge technologies and methodologies employed in the development of nasal sprays, emphasizing their advantages over traditional delivery systems. By enhancing bioavailability, minimizing first-pass metabolism, and improving patient compliance, these innovative sprays are set to revolutionize therapeutic strategies across various medical conditions. We will discuss recent advancements in formulation science, including the use of nanotechnology, mucoadhesive agents, and targeted delivery systems. Additionally, the regulatory landscape and clinical implications of FDA- approved nasal sprays will be examined, highlighting their role in improving treatment outcomes and patient experiences. This comprehensive overview aims to underscore the potential of nasal spray technology as a pivotal player in modern pharmacotherapy.